Synthesis and Anticancer Activity of Novel 9-


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
01 May 2019
Historique:
received: 11 04 2019
revised: 25 04 2019
accepted: 30 04 2019
entrez: 5 5 2019
pubmed: 6 5 2019
medline: 14 8 2019
Statut: epublish

Résumé

Berberine is a bioactive isoquinoline alkaloid derived from many plants. Although berberine has been shown to inhibit growth and induce apoptosis of several tumor cell lines, its poor absorption and moderate activity hamper its full therapeutic potential. Here, we describe the synthesis of a series of 9-

Identifiants

pubmed: 31052469
pii: ijms20092169
doi: 10.3390/ijms20092169
pmc: PMC6539820
pii:
doi:

Substances chimiques

Antineoplastic Agents 0
Berberine 0I8Y3P32UF

Types de publication

Journal Article

Langues

eng

Déclaration de conflit d'intérêts

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Références

Chem Res Toxicol. 2001 Nov;14(11):1529-34
pubmed: 11712911
Leuk Res. 2003 Jan;27(1):65-72
pubmed: 12479854
Fitoterapia. 2003 Dec;74(7-8):702-5
pubmed: 14630179
J Magn Reson. 2006 Jan;178(1):42-55
pubmed: 16188474
J Photochem Photobiol B. 2006 Dec 1;85(3):163-76
pubmed: 16905326
Toxicol In Vitro. 2007 Feb;21(1):25-31
pubmed: 17011159
Photochem Photobiol. 2008 Jan-Feb;84(1):202-8
pubmed: 18173721
Biochemistry. 2008 Mar 11;47(10):3225-34
pubmed: 18275156
Free Radic Res. 2009 May;43(5):457-69
pubmed: 19353392
J Cell Biochem. 2009 Aug 1;107(5):955-64
pubmed: 19492307
Anticancer Drugs. 2009 Oct;20(9):757-69
pubmed: 19704371
J Enzyme Inhib Med Chem. 2010 Aug;25(4):577-89
pubmed: 20235755
Org Biomol Chem. 2011 Jul 7;9(13):4936-47
pubmed: 21597620
PLoS One. 2011;6(6):e21416
pubmed: 21738655
J Phys Chem B. 2012 Mar 8;116(9):3037-44
pubmed: 22313410
Mini Rev Med Chem. 2011 Nov;11(13):1122-9
pubmed: 22353221
PLoS One. 2012;7(5):e36418
pubmed: 22574158
Oncol Lett. 2012 Jun;3(6):1263-1267
pubmed: 22783430
Biochem Pharmacol. 2012 Nov 15;84(10):1260-7
pubmed: 22842630
Bioorg Med Chem Lett. 2013 Jan 1;23(1):305-9
pubmed: 23182088
Mol Med Rep. 2013 Aug;8(2):505-10
pubmed: 23732865
Bioorg Med Chem Lett. 2014 Apr 1;24(7):1762-5
pubmed: 24613165
Apoptosis. 2014 Jun;19(6):946-57
pubmed: 24664781
J Biol Phys. 2014 Sep;40(4):335-45
pubmed: 25033818
Braz J Med Biol Res. 2015 Feb;48(2):111-9
pubmed: 25517919
World J Gastroenterol. 2015 Apr 14;21(14):4225-31
pubmed: 25892872
Cell Physiol Biochem. 2015;36(3):956-65
pubmed: 26087719
Oncol Res. 2014;22(3):147-57
pubmed: 26168133
Acta Biochim Biophys Sin (Shanghai). 2015 Oct;47(10):824-33
pubmed: 26341980
Oncotarget. 2015 Nov 3;6(34):35625-35
pubmed: 26462146
Nutr Cancer. 2015;67(8):1293-304
pubmed: 26492225
Evid Based Complement Alternat Med. 2015;2015:796306
pubmed: 26508985
Expert Opin Ther Pat. 2016;26(2):229-43
pubmed: 26610159
Cell Mol Biol (Noisy-le-grand). 2015 Dec 14;61(8):37-43
pubmed: 26667771
Oncotarget. 2016 Jan 19;7(3):2985-3001
pubmed: 26672764
Asian J Androl. 2016 Jul-Aug;18(4):607-12
pubmed: 26698234
Fitoterapia. 2016 Mar;109:274-82
pubmed: 26851175
J Antibiot (Tokyo). 2016 Oct;69(10):741-746
pubmed: 26932407
Oncol Rep. 2016 Jul;36(1):567-72
pubmed: 27177238
Mol Carcinog. 2017 Feb;56(2):402-411
pubmed: 27208550
Oncotarget. 2016 Oct 11;7(41):66944-66958
pubmed: 27557493
Bioorg Med Chem Lett. 2016 Oct 1;26(19):4799-4803
pubmed: 27561717
Apoptosis. 2017 Feb;22(2):229-238
pubmed: 27796611
Acta Pharmacol Sin. 2017 Feb;38(2):157-167
pubmed: 27917872
Int J Mol Sci. 2017 Jan 01;18(1):
pubmed: 28045432
Immunol Invest. 2017 May;46(4):341-360
pubmed: 28287857
Mini Rev Med Chem. 2018;18(17):1424-1441
pubmed: 28325147
J Cell Mol Med. 2018 Jan;22(1):600-612
pubmed: 28840963
Biomed Pharmacother. 2017 Nov;95:1225-1231
pubmed: 28931215
Int J Mol Sci. 2018 Jan 23;19(2):null
pubmed: 29360760
Anticancer Agents Med Chem. 2018;18(11):1639-1648
pubmed: 30014806
Molecules. 2018 Nov 28;23(12):null
pubmed: 30487471
Molecules. 2018 Dec 28;24(1):null
pubmed: 30597911
Front Pharmacol. 2019 Feb 14;10:9
pubmed: 30837865
J Immunol Methods. 1983 Dec 16;65(1-2):55-63
pubmed: 6606682
Am J Pathol. 1995 Jan;146(1):3-15
pubmed: 7856735

Auteurs

Viktor Milata (V)

Institute of Organic Chemistry, Catalysis and Petrochemistry, Faculty of Chemical and Food Technology, Slovak University of Technology, Radlinskeho 9, 812 37 Bratislava, Slovakia. viktor.milata@stuba.sk.

Alexandra Svedova (A)

Institute of Biochemistry and Microbiology, Faculty of Chemical and Food Technology, Slovak University of Technology, Radlinskeho 9, 812 37 Bratislava, Slovakia. s.svedova@gmail.com.

Zuzana Barbierikova (Z)

Institute of Physical Chemistry and Chemical Physics, Faculty of Chemical and Food Technology, Slovak University of Technology in Bratislava, Radlinskeho 9, 812 37 Bratislava, Slovakia. zuzana.barbierikova@stuba.sk.

Eva Holubkova (E)

Institute of Organic Chemistry, Catalysis and Petrochemistry, Faculty of Chemical and Food Technology, Slovak University of Technology, Radlinskeho 9, 812 37 Bratislava, Slovakia. evaholubicka@gmail.com.

Ingrid Cipakova (I)

Cancer Research Institute, Biomedical Research Center, University Science Park for Biomedicine, Slovak Academy of Sciences, Dubravska cesta 9, 845 05 Bratislava, Slovakia. ingrid.cipakova@savba.sk.

Dana Cholujova (D)

Cancer Research Institute, Biomedical Research Center, University Science Park for Biomedicine, Slovak Academy of Sciences, Dubravska cesta 9, 845 05 Bratislava, Slovakia. dana.cholujova@savba.sk.

Jana Jakubikova (J)

Cancer Research Institute, Biomedical Research Center, University Science Park for Biomedicine, Slovak Academy of Sciences, Dubravska cesta 9, 845 05 Bratislava, Slovakia. jana.jakubikova@savba.sk.

Miroslav Panik (M)

Institute of Management, Slovak University of Technology, 812 33 Bratislava, Slovakia. miroslav.panik@stuba.sk.

Sona Jantova (S)

Institute of Biochemistry and Microbiology, Faculty of Chemical and Food Technology, Slovak University of Technology, Radlinskeho 9, 812 37 Bratislava, Slovakia. sona.jantova@stuba.sk.

Vlasta Brezova (V)

Institute of Physical Chemistry and Chemical Physics, Faculty of Chemical and Food Technology, Slovak University of Technology in Bratislava, Radlinskeho 9, 812 37 Bratislava, Slovakia. vlasta.brezova@stuba.sk.

Lubos Cipak (L)

Cancer Research Institute, Biomedical Research Center, University Science Park for Biomedicine, Slovak Academy of Sciences, Dubravska cesta 9, 845 05 Bratislava, Slovakia. lubos.cipak@savba.sk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH